Genentech Articles
CHMP recommends approval of Avastin for NSCLC
30 July 2007
Japan stock market week to July 16, 2007
23 July 2007
Tercica and Genentech sign R&D deal
16 July 2007
Cancer, RA drugs boost Genentech
16 July 2007
Cephalon plans to file Treanda NDA in 3rd qtr
9 July 2007
Abbott and Genentech collaborate on oncology
2 July 2007
New ABPI guideline for patient data published
21 May 2007
Roche's Avastin launched in the UK
21 May 2007
UK's NICE blamed for poor cancer care
21 May 2007
Rituxan yields promising results in RRMS
14 May 2007
Biogen's 1st-qtr income climbs 7% to $131M
14 May 2007
Sangamo to license ZPFs to Genentech
7 May 2007
Genentech extends stock repurchase program
30 April 2007
BioInvent reports 1st-qtr profits of 73M Kronor
23 April 2007
Clarification to FDA's Tykerb approval
26 March 2007
Argenta signs second Genentech R&D accord
12 March 2007
Genentech's cell culture site nears completion
12 March 2007
Japan stock market week to Feb 26, 2007
5 March 2007
FDA requests label warning on Genentech's Xolair
26 February 2007
Genentech updates of Cabilly patent re-examination
26 February 2007
BioInvent's losses fall 22% as sales climb 80%
26 February 2007
Proacta raises $35M to fund its PR-104 development
19 February 2007
Roche posts record 2006 net profits, boosted by cancer drugs
12 February 2007
Raptiva impresses in psoriasis study
12 February 2007
Stock Commentary - Europe - week to Jan 29, 2007
5 February 2007
FTC request delays Genentech and Tanox merger
5 February 2007
Promotions at Genentech
29 January 2007
Stock Commentary - Europe - week to Jan 15, 2007
22 January 2007
Stock Commentary - New York week to Jan 15, 2007
22 January 2007
US Supreme Court decision "will alter structure of future deals"
22 January 2007
BioInvent enters BI-204 accord with Genentech
22 January 2007
Tanox approves $919M Genentech merger
22 January 2007
US Supreme Court's MedImmune ruling eases patent challenges
15 January 2007
Genentech in-licenses SGN-40 in R&D deal
15 January 2007
Roche/Genentech
15 January 2007
Ian Clark joins Vernalis board
8 January 2007
Galapagos to buy ProSkelia for $16.5M
22 December 2006
FDA issues PML warning for Rituxan
22 December 2006
GSK and Genmab to develop HuMax CD20
22 December 2006
Generex's cancer vacc well-tolerated
22 December 2006
Pharmaxis' Bronchitol fast-tracked by FDA
18 December 2006
November a lackluster month for biotechnology stocks, says Burrill
18 December 2006
AC Immune/Genentech sign AD R&D deal worth up to $300M
11 December 2006
Herceptin availability in UK is paid for by "dropped" patients
4 December 2006
BMJ defends UK's NICE legal challenge
4 December 2006
Herceptin gets FDA ok for HER2 node
27 November 2006
Genentech to acquire Tanox for $919M
20 November 2006
Lonza in two biomanufacturing deals with Genentech
13 November 2006
Freedonia predicts 7% per year rise in US enzyme demand to 2010
30 October 2006
Hana Biosci in-licenses menadione
23 October 2006
Genentech's blockbuster Avastin gains new cancer indication; $2B sales predicted in 2007
23 October 2006
Genentech's 3rd-qtr GAAP net leaps 58%
16 October 2006
Less price flexibility, more innovation: the market dynamics of targeted therapeutics
16 October 2006
Novartis' Lucentis improves visual acuity in wet AMD, two pivotal Ph III studies find
16 October 2006
Rituxan gets FDA approval for 1st-line use in NHL
16 October 2006
Genentech and CGI enter $25M alliance
9 October 2006
Stock Commentary - Europe - week to Oct 2, 2006
9 October 2006
Stock Commentary - Europe - week to Sept 18, 2006
25 September 2006
Biotech stocks in holding pattern for August, says Burrill report
18 September 2006
FDA requests new data on Genentech's Avastin
18 September 2006
Big Pharma needs to catch up with specialty detailing
18 September 2006
Curis opts out of Genentech Hedgehog alliance
11 September 2006
Headlines 25 years ago this week....
4 September 2006
Rituxan meets primary endpoint in MS trial
4 September 2006
GPC Biotech begins Ph II satraplatin study in NSCLC
7 August 2006
Inotek and Genetech sign R&D deal
31 July 2006
Zymogenetics starts combined IL-21 and Rituxan study
17 July 2006
Stock Commentary - New York week to July 10, 2006
17 July 2006
Stock Commentary - New York week to July 3, 2006
10 July 2006
- Novo Nordisk's diabetes drug Victoza produced 8% weight loss in Ph III obesity trial
- Is the diabetes market facing a blockbuster-free future?
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
- Johnson & Johnson expects 10 NDA filings by 2017, saying pharma sector poised for growth
